Bupropion is the Optimal Medication to Add for a Patient with Mood Disorder
For a patient with a mood disorder, bupropion is the most appropriate medication to add, offering effective treatment with fewer side effects such as sexual dysfunction compared to other antidepressants. 1, 2
Rationale for Choosing Bupropion
Bupropion offers several advantages as an augmentation strategy for mood disorders:
- Acts through a unique mechanism as a norepinephrine-dopamine reuptake inhibitor
- Lower risk of sexual dysfunction compared to SSRIs
- Less likely to cause sedation or weight gain
- Effective for both unipolar depression and bipolar depression
- Can be used as augmentation to existing antidepressant therapy
Dosing and Administration
- Starting dose: 150 mg once daily of extended-release formulation
- Target dose: 300 mg once daily
- After 4 days, may increase to 300 mg once daily if tolerated 3
- Maximum recommended dose: 450 mg daily (do not exceed this dose, especially in bipolar disorder) 4
- Available in three formulations:
- Immediate release (IR): administered three times daily
- Sustained release (SR): administered twice daily
- Extended release (XL): administered once daily 5
Monitoring and Precautions
Key Warnings
- Seizure risk: Dose-related; limit daily dose to 450 mg and increase gradually 3
- Activation of mania/hypomania: Screen for bipolar disorder before initiating 3
- Neuropsychiatric symptoms: Monitor for agitation, anxiety, and other mood changes 3
- Blood pressure: Monitor before and during treatment as bupropion can increase blood pressure 3
Common Side Effects
- Dry mouth, nausea, insomnia, dizziness, agitation, anxiety, tremor 3
- Less likely to cause sexual dysfunction or weight gain than SSRIs 2
Special Considerations
Drug Interactions
CYP2D6 inhibition: Bupropion inhibits CYP2D6 and can increase concentrations of:
- Antidepressants (venlafaxine, nortriptyline, imipramine, paroxetine, fluoxetine, sertraline)
- Antipsychotics (haloperidol, risperidone)
- Beta-blockers (metoprolol)
- Type 1C antiarrhythmics 3
Contraindicated with:
- MAOIs (allow 14 days between stopping MAOIs and starting bupropion)
- Seizure disorders
- Current or prior diagnosis of bulimia or anorexia nervosa
- Abrupt discontinuation of alcohol, benzodiazepines, or barbiturates 3
Combination Strategies
- Bupropion can be effectively combined with SSRIs or SNRIs for treatment-resistant depression 6, 7
- When combined with venlafaxine, significant reduction in depressive symptoms has been observed in treatment-resistant cases 6
- The combination of escitalopram and bupropion-SR has shown high response rates (62%) and remission rates (50%) 7
Evidence for Bipolar Depression
- Bupropion has shown efficacy in bipolar depression with potentially lower risk of inducing switches to hypomania or mania 4
- In difficult-to-treat bipolar depression, 8 of 13 patients showed >50% reduction in depression scores within 4 weeks when bupropion was added to mood stabilizers 4
- When treating bipolar depressed patients, do not exceed 450 mg daily to minimize switch risk 4
Clinical Decision Algorithm
- If patient has unipolar depression: Start bupropion at 150 mg daily, titrate to 300 mg daily after 4 days
- If patient has bipolar disorder: Ensure patient is on a mood stabilizer before adding bupropion
- If patient is on other antidepressants: Bupropion can be added as augmentation therapy
- If patient has concerns about sexual dysfunction: Bupropion is preferred over SSRIs
- If patient has seizure history: Consider alternative medication as bupropion lowers seizure threshold
By following this evidence-based approach, bupropion offers an effective option for augmenting treatment in patients with mood disorders while minimizing common side effects associated with other antidepressants.